key: cord-0762093-ibf4sijj
authors: Gómez, N.; Wigdorovitz, A.; Castañón, S.; Gil, F.; Ordá, R.; Borca, M. V.; Escribano, J. M.
title: Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus
date: 2000
journal: Arch Virol
DOI: 10.1007/s007050070087
sha: 1f6ebfe10bb34747fb91008cf07d26b6e9e1614a
doc_id: 762093
cord_uid: ibf4sijj

Transgenic plants represent an inexpensive alternative to classical fermentation systems for production of recombinant subunit vaccines. Transgenic potato plants were created that express the N-terminal domain of the glycoprotein S (N-gS) from Transmissible gastroenteritis coronavirus (TGEV), containing the major antigenic sites of the protein. Extracts from potato tubers expressing N-gS were inoculated intraperitoneally to mice, and the vaccinated mice developed serum IgG specific for TGEV. Furthermore, when potato tubers expressing N-gS were fed directly to mice, they developed serum antibodies specific for gS protein, demonstrating the oral immunogenicity of the plant derived spike protein from TGEV.

Transgenic plants represent an inexpensive alternative to classical fermentation systems for production of recombinant subunit vaccines. Transgenic potato plants were created that express the N-terminal domain of the glycoprotein S (N-gS) from Transmissible gastroenteritis coronavirus (TGEV), containing the major antigenic sites of the protein. Extracts from potato tubers expressing N-gS were inoculated intraperitoneally to mice, and the vaccinated mice developed serum IgG specific for TGEV. Furthermore, when potato tubers expressing N-gS were fed directly to mice, they developed serum antibodies specific for gS protein, demonstrating the oral immunogenicity of the plant derived spike protein from TGEV. * Transmissible gastroenteritis coronavirus (TGEV) is the causative agent of acute diarrhea of newborn piglets that provokes high rate mortalities in affected farms. Protective immunity against this disease has to be developed in pregnant sows in order to confer passive protection to the piglets trough colostrum and milk. Neutralizing antibodies against the virus are directed mainly to glycoprotein S [12, 15] , and relevant epitopes in neutralization have been mapped into the Nterminal domain of this protein [8] . Four major antigenic sites have been described in the globular part of glycoprotein S (gS), of which site A is the immunodominant [9] [10] [11] 21] .

The protection of suckling piglets against an enteric TGEV infection is based on the uptake of specific lactogenic antibodies, mainly of the IgA class, in the milk of TGEV-immune mothers [4] . Since the concept of vaccine production in transgenic plants was first introduced by Mason and co-workers in 1992 [16] , the oral immunogenicity of several antigens derived from human and animal pathogens expressed in transgenic plants have been demonstrated [1, 14, 17, 22, 24] . Oral immunization by edible vaccines produced in transgenic plants could stimulate immune responses at the portal entrance of many pathogens, facilitating the design of large-scale immunization programs. The gS from TGEV is an excellent model for developing oral vaccines against enteric pathogens of mammals because of its immunogenicity and resistance to degradation in the gut. Here, we report the expression of recombinant N-terminal domain of gS (N-gS) from TGEV in potato tubers and, more importantly, we demonstrate that transgenic potato tubers fed directly to mice stimulate the systemic production of antibodies against gS. These results contribute to support the feasibility of developing edible vaccines using as vectors transgenic plants expressing immunodominant antigens.

The plant expression vector pRoK I (Fig. 1A) , derived from pRoK2 plasmid [2] , containing the N-terminal domain encoding sequence from gS, and previously used to transform arabidopsis plants [13] , was used to transform potato plants (Solanum tuberosum cv. Desirée), as previously described [7] . Briefly, leaf explants from 4-week-old potato plants were infected with recombinant A. tumefaciens (strain LBA4404). The inoculated leaves were blotted dry and placed on solidified shoot-promoting Murashige and Skoog medium [19] supplemented with 30 g of glucose per liter, 6 M zeatin riboside, and 0.02 M naphthalenacetic acid (CM medium). After 2 days of cocultivation, the plants were placed on CM medium supplemented with 300 mg of ticarcillin and 100 mg of kanamycin per liter (CMKT medium). After 3 to 4 weeks, regenerants appeared on CMKT medium at a frequency of 55%. Each leave explant usually gave rise to four or five shoots. Regenerated shoots were subcultured and rooted on selective MS medium supplemented with 10 g of sucrose and 50 mg of kanamycin per liter. The putative transgenic plants were transferred to a sterile peat-perlite (2:1) mixture and incubated in a growth chamber under normal humidity and light conditions. Fifteen different transformed potato clones were obtained by this methodology.

The presence of the N-gS gene in rooted plants was investigated by polymerase chain reaction (PCR). The DNA from fresh leaves, obtained as described elsewhere [13] , was amplified (1389 bp fragment of gS) by using a forward primer, 5 -GCGCGGATCCATGAAAAACTATTTGTGG-3 , and a reverse primer, 5 -GCGCGGTACCCGATGTGAAGCTATTG-3 . All independent transgenic potato plant lines were positive when screened for the presence of the recombinant gene by PCR analysis. Agarose electrophoresis analysis of the amplified products consistently showed the presence of the expected band of 1389 bp (Fig. 1B) in all putative N-gS transgenic lines. No amplification product was obtained in N-gS-unrelated transformed lines derived from vector pRoK2 or in wild-type potato.

The presence of the recombinant polypeptide in the plants harboring the foreign sequence was investigated by ELISA and Western blotting using an anti-TGEV polyclonal serum. Proteins from potato tubers were obtained by homogenization of tubers in a blender with liquid nitrogen, and the resulting powder was resuspended in buffer (0.3 g of fresh wt/ml) containing 10 mM 2-(Nmorpholino)ethanesulfonic acid (MES), pH 6, 10 mM NaCl, 5 mM EDTA, 0.6% Triton X-100, 0.25 M sucrose, 0.15 mM spermine, 0.5 mM spermidine, 10 mM DTT, and 1 mM phenylmethylsulfonyl fluoride. The extract was filtered and centrifuged 10 min at 12,000 g, and the resulting supernatant was used for N-gS polypeptide expression analyses. ELISA assay for detection of N-gS polypeptide in plant extracts was carried out essentially as previously described [13] , using to coat the plates a mixture of two monoclonal antibodies, 6AC3 and 8DH8 (kindly provided by Dr L. Enjuanes, Centro Nacional de Biotecnología, CSIC, Spain), recognizing the antigenic sites A and D of the gS, respectively [8] . Results demonstrated that potato tuber extracts from all analyzed plants were positive on ELISA (Fig. 1C ). An experiment performed to quantify the expression of recombinant gS protein expression in the potato tubers, using purified TGEV and different concentrations of transgenic plant extracts in ELISA [13] , showed similar levels of expression in potato tubers that those found in transgenic arabidopsis (0.02-0.07% of total soluble tuber protein). Western blot analyses of the plant extracts with anti-gS antibodies revealed no specific reactions with any protein (data not shown). It could be due to the low levels of recombinant protein expression and to the conformational nature of most of the immunodominant epitopes present in this protein.

Tubers from transgenic potato plants expressing N-gS were used to immunize mice. Adult (60 to 90 days old) male BALB/c mice were immunized intraperitoneally on days 0, 15, 30 and 45 with either potato extracts from transgenic plants expressing N-gS or potato plants transformed with pRoK2 plasmid (150 g of potato extract in incomplete Freund's adjuvant per animal per injection). Ten days after the last booster, mice sera (different dilutions in PBS-Tween 20) were evaluated for anti-gS-specific antibodies by ELISA using purified TGEV (0.2 g) as antigen. A goat anti-mouse antibodies (1:500) was used to reveal immunocomplexes. Figure 2A shows that all sera reacted with the virus showing, as expected, different titers.

To determine oral immunogenicity of the recombinant protein, BALB/c mice were fed with potato tubers expressing N-gS (3 times per week with 2 g of transgenic potato tuber during a two months period). Sera from these animals were analyzed by ELISA, showing an specific antibody response against the plantderived gS, indicating the oral immunogenicity of the expressed protein (Fig.  2B ). As expected, no antibody response against gS was detected in mice fed with potato tubers expressing an unrelated gene (VP1 of foot and mouth disease virus).

The specificity of sera reactivity in ELISA with the virus-induced protein was confirmed by immunoprecipitation of the 35 S-methionine labeled gS expressed by a recombinant vaccinia virus. Immunoprecipitation of glycoprotein S by sera from mice orally immunized was essentially carried out as previously described for mouse antibodies [5, 13] , using CV1-infected cells with a recombinant vaccinia virus expressing the gS (Gómez and Escribano, unpubl. res.). Infected cells were pulse labeled at 14 h post infection for 2 h with 200 Ci/ml of 35 S-methionine (800 Ci/mmol; Amersham International, Amersham, England), and lysed before immunoprecipitation with lysis buffer [13] . The antigen-antibody complexes were analyzed in 7.5% SDS-PAGE. All sera from mice fed with transgenic potatoes expressing N-gS immunoprecipitated the vaccinia virus-induced gS, confirming the specificity of ELISA results obtained with purified TGEV (Fig. 2C ). An immunoblotting analysis of these sera using the vaccinia expressed gS or the TGEV-induced gS transferred to the nitrocellulose strips did not show positive reaction. It suggests a reduced sensitivity of immunoblotting technique in this case to respect to ELISA or immunoprecipitation, in which the protein is in native condition. Finally, an in vitro seroneutralization assay of TGEV by sera from mice immunized either intraperitoneally or orally with potato tuber extracts did not render significant neutralization values of the virus (data not shown).

Antibody responses to the plant-derived N-terminal domain of glycoprotein S polypeptide in immunized mice. A ELISA titers of sera from mice inoculated intraperitoneally with potato tuber extracts expressing the N-terminal domain of glycoprotein S (mice 1 to 6), using purified TGEV as antigen. Mice 7 and 8 represent ELISA titers of two mice immunized with a pRoK 2 transformed plant extract. B ELISA titers of sera from orally immunized mice with transgenic potato tubers expressing the N-terminal domain of glycoprotein S (mice 1 to 10). Mice 11 and 12 represent ELISA titers of two mice immunized orally with a pRoKVP1 transformed potato, expressing VP1 protein from foot and mouth disease virus. C Immunoprecipitation of glycoprotein S expressed by a recombinant vaccinia virus by antibodies present in sera from orally immunized mice with potato tubers expressing the N-terminal domain of the glycoprotein S. A pool of specific monoclonal antibodies was used as a control positive serum (C+) and a serum from a mouse immunized with potato tubers transformed with pRoKVP1 (serum 11) was used as a negative control (C−)

The results presented here demonstrate the feasibility of expressing the Nterminal domain of glycoprotein S in potato plants. However, when the gene encoding the complete gS was used to transform potato plants, only a few transgenic lines were obtained presenting reduced growth rates compared to control plants or plants transformed with the sequence encoding the N-gS. Therefore, we selected the plants expressing the N-gS for further analyses, specially because this protein domain contains the four major antigenic sites of gS [9] [10] [11] 21] . The selected transgenic plants showed expression levels similar to that described with equivalent constructs in arabidopsis plants [13] , and those found expressing hepatitis B surface antigen, rabies virus glycoprotein or VP1 from foot and mouth disease virus [6, 16, 18] . The demonstration that many proteins from pathogens, including some expressed in transgenic plants [14, 17, 24] , are immunogenic when administered orally, encourage the study of other antigens expressed in plants with the goal of developing edible vaccines. Glycoprotein S from TGEV is an interesting model since this protein is resistant, at least when incorporated into the viral particle, to the gut degradation. In addition, the protective immune responses against TGEV have to be stimulated at the mucosal surfaces in order to elicit secretory and lactogenic immunity [9, 10, 20, 23 ]. In the above described work, we have demonstrated that the N-terminal domain of glycoprotein S expressed in potato plants is immunogenic when mice were fed with the transgenic potato tubers. Antibody titers obtained in mice orally immunized were higher than those obtained after intraperitoneal immunization. It could be explained by the differences in the antigen doses used in each administration route. Unfortunately, we were unable to induce neutralizing antibodies with the potato-derived gS independently of the immunization route used. Interestingly, in a similar experiment performed previously, all mice intramuscularly immunized with arabidopsis-derived gS presented a significant neutralization activity in their sera [13] . The differences in neutralization activity between sera from mice immunized with the arabidopsis-derived gS and potato-derived gS could be influenced by the postranslational processing of the glycoprotein depending of the plant used, or due to the plant proteins that, accompanying the recombinant gS, differentially modify in each plant species its spatial structure.

Interestingly, in these experiments we have observed that a long protocol of oral immunization, using transgenic plants as antigen delivery vector, regularly elicited a significant immune response to the recombinant antigen, even when it is expressed at low levels. Similar results were previously obtained by our group using the structural protein VP1 from foot and mouth disease virus expressed in transgenic alfalfa [24] and agree with reports from others using transgenic plants as edible vaccines [1, 14, 17, 22] . In all these cases, as well as it happens with the oral administration of the plant-derived N-gS, no immunotolerance was established in any of the vaccinated individuals. This observation is very important in case of evaluating, in the future, the feasibility of vaccinating farm animals through the diet. These results, also, make reasonable to extend similar immunological studies to the natural host, the swine, in order to test the lactogenic immunity conferred to suckling piglets by feeding pregnant sows with the plant-derived gS.

Efficacy of a food plant-based oral cholera toxin B subunit vaccine

Expression of biologically active viral satelite RNA from nuclear genome of transformed plants

Agrobacterium mediated gene transfer by infiltration of adult Arabidopsis thaliana plants

Transmissible gastroenteritis

Monoclonal antibody 2F4/11 recognizes the ␣ chain of the porcine ␤ 2 integrin involved in adhesion and complement mediated phagocytosis

Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants

Immunization with potato plants expressing VP6O protein protects against Rabbit hemorrhagic disease virus

Antigenic structure of E2-glycoprotein of transmissible gastroenteritis coronavirus

Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus

Characterization of the IgA and subclass IgG responses to neutralizing epitopes after infection of pregnant sows with the transmissible gastroenteritis virus or the antigenically related porcine respiratory coronavirus

Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S

Antigenicity of structural components from porcine transmissible gastroenteritis virus

Expression of immunogenic glycoprotein S polypeptides from Transmissible gastroenteritis coronavirus in transgenic plants

Oral immunization with a recombinant bacterial antigen produced in transgenic plants

Critical epitopes in transmissible gastroenteritis virus neutralization

Expression of hepatitis B surface antigen in transgenic plants

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

Expression of the rabies virus glycoprotein in transgenic tomatoes

A revised medium for rapid growth and bioassays with tobacco tissue cultures

Passive immunity in transmissible gastroenteritis of swine: immunoglobulin classes of milk antibodies after oral-intranasal inoculation of sows with a live low cell culture-passaged virus

Antigenic homology among coronaviruses related to transmissible gastroenteritis virus

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus

Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parental immunization with alfalfa transgenic plants expressing the viral structural protein VP1

Received January 19, 2000